XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Carl Uli Bialucha|Molecular Cancer Therapeutics|2023Cited by 9